U.S. Department of Health & Human Services      Search the NIH Website
          Virtual Tour
          Staff Directory
          En Español Site Menu Home
			
			Health Information
				Health Care Providers & Facilities
							Health Info Lines
							HealthCare.gov
							Science Education Resources
							NIH Clinical Research Trials and You
							Talking to Your DoctorMore »
					Search Health Topics
						Quick Links
						MedlinePlus Health Info
							NIH News in Health
							Wellness Toolkits
			
			Grants & Funding
				Grants Home Page
							Find Funding
							Due Dates
							How to Apply
							About Grants
							Policy & Compliance
							Grants News/Blog
							Contracts
							Loan RepaymentMore »
					Quick Links
						RePORT
							eRA Commons
							NIH Common Fund
			
			News & Events
				News Releases
							Digital Media Kits
							Media Resources
							Media Contacts
							Images and B-roll
							Events
							Social MediaMore »
					Quick Links
						NIH News in Health
							NIH Research Matters
							NIH Record
			
			Research & Training
				Medical Research Initiatives
							Science Highlights
							Science Education
							Research in NIH Labs & Clinics
							Training Opportunities
							Library Resources
							Research Resources
							Clinical Research Resources
							Safety, Regulation and GuidanceMore »
					Quick Links
						PubMed
							Stem Cell Information
							OppNet
							NIDB
							NIH Blueprint for Neuroscience Research
			
			Institutes at NIH
				List of Institutes and Centers
							NIH Office of the Director
							Directors of NIH Institutes and Centers
							NIH Institute and Center Contact InformationMore »
					Quick Links
						NCI
              	NEI
              	NHLBI
              	NHGRI
              	NIA
              	NIAAA
              	NIAID
              	NIAMS
              	NIBIB
              	NICHD
              	NIDCD
              	NIDCR
              	NIDDK
              	NIDA
              	NIEHS
              	NIGMS
              	NIMH
              	NIMHD
              	NINDS
              	NINR
              	NLM
              	CC
              	CIT
              	CSR
              	FIC
              	NCATS
              	NCCIH
			
			About NIH
				Who We Are
							What We Do
							Jobs at NIH
							Visitor Information
							Frequently Asked Questions
							Contact UsMore »
					Quick Links
						The NIH Director
							Take the Virtual Tour
							NIH...Turning Discovery Into Health®
							Impact of NIH Research
							Science, Health, and Public Trust
 You are here Home News & Events NIH Research Matters
 NIH Research Matters
 March 12, 2024 How excess niacin may promote cardiovascular disease At a Glance A metabolite of niacin (vitamin B3) was associated with elevated risk of heart attack and stroke, likely due to inflammation in arteries.
	The findings suggest new measures that may prevent or treat cardiovascular disease and raise concerns about the health effects of too much niacin.
 Foods rich in vitamin B3, or niacin, surround a drawing of a niacin molecule: avocado, nuts, spinach, bean, broccoli, egg, tomato, and chicken breast slices.
 Cardiovascular disease (CVD) is disease of the heart and blood vessels. CVD is a leading cause of death in the United States for both men and women. Despite advances in prevention and treatment, it remains widespread. This suggests that there may be risk factors that are not yet recognized. To investigate, an NIH-funded research team, led by Dr. Stanley Hazen at the Cleveland Clinic, searched for products of metabolism that might contribute to CVD risk. The results appeared in *Nature Medicine* on February 19, 2024. The team analyzed blood plasma from more than 1,100 people for molecules associated with major adverse cardiac events, such as heart attacks and strokes. They identified two such molecules, 2PY and 4PY. Both of these are produced when the body breaks down excess niacin. Niacin, also known as nicotinic acid or vitamin B3, is an essential part of the diet. Many countries require that staple foods like cereals, flour, oats, and grains be fortified with niacin to prevent deficiency. In the United States, niacin must be added to “enriched” foods. The recommended amount of niacin is 14–18 mg/day for adults. High–dose niacin (1,500–2,000 mg/day) was also one of the first cholesterol-lowering drugs. But studies found that niacin, unlike newer cholesterol-lowering drugs, did not lower the risk of heart attack or stroke. Researchers hadn’t understood why. The researchers examined 2PY and 4PY levels in two other groups, one American and one European, totaling more than 3,000 people. They confirmed that elevated levels of either molecule were associated with increased risk of major cardiac events. People with 2PY or 4PY levels in the top 25% had 1.6-2 times the risk of major cardiac events over the next three years as those with levels in the bottom 25%, even after controlling for other CVD risk factors. Levels of both 2PY and 4PY were associated with variants in a gene called *ACMSD*. The team found that levels of another protein, called VCAM-1, were also associated with *ACMSD* variants. Furthermore, VCAM-1 levels correlated with 2PY and 4PY levels. VCAM-1 is known to help white blood cells stick to the walls of blood vessels as part of the inflammatory response. This contributes to the formation of plaque in arteries. Injecting mice with 4PY, but not 2PY, increased the amount of VCAM-1 on the walls of blood vessels and the number of stuck white blood cells. These findings suggest that excess niacin may be a risk factor for CVD. When excess niacin is broken down into 4PY, this breakdown product activates inflammatory pathways that are known to promote plaque formation in arteries. This may increase the risk of major cardiac events. “Niacin’s effects have always been somewhat of a paradox,” Hazen says. “Despite niacin lowering cholesterol, the clinical benefits have always been less than anticipated based on the degree of LDL [cholesterol] reduction. This led to the idea that excess niacin caused unclear adverse effects that partially counteracted the benefits of LDL lowering. We believe our findings help explain this paradox.” The study results could lead to better assessment of CVD risk. They also highlight the importance of further research on the health effects of supplemental niacin. —by Brian Doctrow, Ph.D.
 Related Links Erythritol and Cardiovascular EventsIrregular Sleep Patterns May Raise Risk of Heart DiseaseStress Links Poverty to Inflammation and Heart DiseaseEating Red Meat Daily Triples Heart Disease-Related ChemicalHow Dietary Factors Influence Disease RiskHealthy Body, Happy Heart: Improve Your Heart HealthNiacin: Fact Sheet for ConsumersCoronary Heart DiseaseHeart-Healthy LivingHeart Health and Aging **References:**A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Ferrell M, Wang Z, Anderson JT, Li XS, Witkowski M, DiDonato JA, Hilser JR, Hartiala JA, Haghikia A, Cajka T, Fiehn O, Sangwan N, Demuth I, König M, Steinhagen-Thiessen E, Landmesser U, Tang WHW, Allayee H, Hazen SL. *Nat Med.* 2024 Feb;30(2):424-434. doi: 10.1038/s41591-023-02793-8. Epub 2024 Feb 19. PMID: 38374343. **Funding:**NIH’s National Heart, Lung, and Blood Institute (NHLBI), Office of Dietary Supplements (ODS), National Institute of Environmental Health Sciences (NIEHS), and National Institute of General Medical Sciences (NIGMS); Deutsche Forschungsgemeinschaft; Charité–Universitätsmedizin Berlin; Berlin Institute of Health; Sanofi-Aventis Deutschland GmbH.
 In this Edition
  
  Talk therapy cuts risk of postpartum depression
  How excess niacin may promote cardiovascular disease
  Designing a new antibiotic to combat drug resistance
Search NIH Research Matters
  
  Search NIH Research Matters' stories
Connect with Us
  
  Subscribe to get NIH Research Matters by email

RSS feed
	Facebook
	Email us**Mailing Address:**
	NIH Research Matters
	Bldg. 31, Rm. 5B52, MSC 2094
	Bethesda, MD 20892-2094
Popular Stories
  
  Plastic particles in bottled water

Gum disease-related bacteria tied to colorectal cancer

Intermittent fasting for weight loss in people with type 2 diabetes

How excess niacin may promote cardiovascular disease

How SARS-CoV-2 contributes to heart attacks and strokes
About NIH Research Matters
  
  **Editor:** Harrison Wein, Ph.D.

**Assistant Editors:** Vicki Contie and Brian Doctrow, Ph.D.

***NIH Research Matters***is a weekly update of NIH research highlights reviewed by NIH’s experts. It's published by the Office of Communications and Public Liaison in the NIH Office of the Director.

ISSN 2375-9593
 Connect with Us Contact Us
      X
      Facebook
      Instagram
      YouTube
      Flickr
      More Social Media from NIH
 Footer
    NIH Home
      Virtual Tour
      En Español
      Visitor Information
      Frequently Asked Questions
      Privacy Policy
      Disclaimers
      Accessibility
      NIH Website ArchivesNondiscrimination Notice
      Freedom of Information Act
      No Fear Act
      HHS Vulnerability Disclosure
      Office of Inspector General
      USA.govNIH...Turning Discovery Into Health®
    National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892
    U.S. Department of Health and Human Services
 Back to Top